Amoxicillin and Potassium Clavulanate
Generic Name: Amoxicillin Trihydrate and Potassium Clavulanate
Uses & Medical Indications
Indicated for severe or recurrent acute otitis media, acute bacterial sinusitis, community-acquired pneumonia, acute exacerbations of chronic bronchitis, uncomplicated and complicated urinary tract infections (pyelonephritis, recurrent cystitis), skin and soft-tissue infections (cellulitis, animal bites, severe dental abscesses), and intra-abdominal or pelvic infections.
Sinusitis, Acute Otitis Media, Pneumonia, Chronic Bronchitis Exacerbations, Dental Abscesses, Cellulitis, Animal Bites, Urinary Tract Infections, Pyelonephritis
Work Mechanism & Pharmacology
Patient Overview of Work Mechanism
This medicine combines two active agents that work together as a powerful antibacterial team: Amoxicillin attacks and breaks down the bacterial cell wall, causing bacteria to rupture and die. Potassium Clavulanate acts as an enzyme shield, disarming the chemical weapons (beta-lactamase enzymes) that resistant bacteria produce to destroy antibiotics. By neutralizing bacterial resistance, the combination cures deep and persistent infections.
Clinical Mechanism of Action (MoA)
Amoxicillin and Potassium Clavulanate features a synergistic, dual-action bactericidal mechanism of action. Amoxicillin, an aminopenicillin beta-lactam antibiotic, acts by covalently binding to penicillin-binding proteins (PBPs 1A, 1B, 2, and 3) situated within the inner cytoplasmic bacterial cell membrane. This inhibits the terminal transpeptidation stage of peptidoglycan synthesis, disrupting the structural cross-links essential for cell wall rigidity. Ongoing bacterial autolytic enzymes (murein hydrolases) then induce osmotic swelling, cell wall rupture, and bacterial death. Potassium Clavulanate is a beta-lactam structurally related to penicillins that acts as an irreversible 'suicide' competitive inhibitor of beta-lactamase enzymes. It binds covalently to the active catalytic serine residue of beta-lactamases (Richmond-Sykes classes II, III, IV, and V; Ambler classes A and D) produced by resistant bacteria. By permanently inactivating these destructive enzymes, clavulanate shields amoxicillin from enzymatic degradation, restoring amoxicillin's potent bactericidal spectrum against beta-lactamase-producing strains of Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis, Escherichia coli, and Klebsiella pneumoniae.
Dosage & Administration Guidelines
Standard adult dose: 625 mg (500 mg amoxicillin / 125 mg clavulanate) orally every 8 hours, or 1000 mg / 1 g (875 mg amoxicillin / 125 mg clavulanate) orally every 12 hours taken at the start of a meal for 7 to 14 days depending on infection severity.
Pediatric: 25 to 45 mg/kg/day (based on amoxicillin component) orally in divided doses every 12 hours (using the 4:1 or 7:1 ratio formulations) taken at the start of meals. For high-dose otitis media: up to 90 mg/kg/day amoxicillin with 6.4 mg/kg/day clavulanate (14:1 ratio ES-600 formulation).
Standard adult dose if renal function is normal; adjust dosage frequency in patients with moderate to severe renal impairment.
Amoxicillin component: up to 2000-3000 mg/day; Clavulanate component: maximum 250-375 mg/day (excessive clavulanate increases diarrhea risk).
CrCl 10-30 mL/min: 625 mg every 12 hours (do not use 1000 mg / 875/125 tablet). CrCl <10 mL/min: 625 mg every 24 hours. Hemodialysis: 625 mg every 24 hours plus a supplemental dose at the end of dialysis.
Dose with caution; monitor liver function regularly. Contraindicated in patients with a history of amoxicillin/clavulanate-associated cholestatic jaundice or hepatic dysfunction.
Side Effects & Safety Warnings
Diarrhea, nausea, vomiting, loose stools, abdominal bloating, skin rashes, oral or vaginal candidiasis (thrush).
Cholestatic jaundice and acute hepatitis (can occur up to 6 weeks after stopping therapy), Clostridioides difficile colitis, anaphylaxis, erythema multiforme, Stevens-Johnson syndrome, acute interstitial nephritis.
History of serious allergic reaction (anaphylaxis, angioedema) to amoxicillin, penicillins, or any beta-lactam; history of amoxicillin/clavulanate-associated cholestatic jaundice or liver impairment.
Always take right at the beginning of a meal to optimize clavulanate absorption and minimize gastrointestinal side effects like nausea and diarrhea. Avoid in infectious mononucleosis (high rate of erythematous rash).
Interactions (Drugs, Food & Alcohol)
Allopurinol increases the frequency of drug rashes. Probenecid decreases renal excretion of amoxicillin (increasing blood levels) without affecting clavulanic acid. May increase methotrexate serum levels. Enhances anticoagulant effect of warfarin (monitor INR). May reduce oral contraceptive efficacy.
Must be taken at the start of a meal or with food. Food reduces clavulanate-induced gastric intolerance and nausea while promoting optimal absorption.
Avoid alcohol during treatment to prevent compounded liver stress, dehydration, and gastrointestinal symptoms.
Pregnancy & Breastfeeding Safety
Generally considered safe for use in pregnancy when clearly indicated; however, prophylactic use in women with preterm premature rupture of fetal membranes (PPROM) has been associated with increased risk of necrotizing enterocolitis in neonates.
Both components are excreted in trace amounts in breast milk. Generally compatible with breastfeeding under medical guidance; monitor infant for loose stools or thrush.
Patient Counseling & Practical Advice
Take each tablet right before you take your first bite of food to prevent stomach cramps and nausea. Finish the entire course of medication even if your symptoms completely disappear.
Take the dose as soon as remembered with food. If your next dose is due within a few hours, skip the missed dose and resume your regular schedule. Never take two doses together.
Liver function tests (ALT, AST, alkaline phosphatase, bilirubin) in extended therapy; renal function in patients with kidney disease; stool frequency.
Frequently Asked Questions
When to Seek Urgent Medical Attention
Signs of severe anaphylaxis (inability to breathe, swelling of throat or tongue, sudden collapse), blistering or peeling of the skin, or acute hepatic injury.
Content for Amoxicillin and Potassium Clavulanate was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:
- Central Drugs Standard Control Organization (CDSCO) — CDSCO Essential Medicine Guidelines - Amoxicillin & Clavulanate
- World Health Organization (WHO) — WHO Model List of Essential Medicines - Access Antibiotics Formulary
- British National Formulary (BNF) — Co-amoxiclav (Amoxicillin with Clavulanic Acid) Prescribing Monograph
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.